By special request of the US Food and Drug Administration, Briotech is invited to present its research supporting prion inactivation with use of BrioHOCl™ at the FDA Silver Springs, MD location.
United States Food and Drug Administration
February 06, 2018
High Level Inactivation of Prions and Other Infectious Pathogens with Novel Preparations of (BrioHOCl™) Hypohalous Acids
Briotech Presents Prion Research at the US FDA
Empty content. Please select category to preview